{
  "nctId": "NCT05159583",
  "briefTitle": "In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Rural Homes",
  "officialTitle": "Commercializing In-Home Supportive Technology for Dementia Caregivers",
  "protocolDocument": {
    "nctId": "NCT05159583",
    "filename": "Prot_002.pdf",
    "label": "Study Protocol",
    "date": "2023-07-12",
    "uploadDate": "2025-01-31T18:18",
    "size": 110584,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05159583/document/Prot_002.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "SINGLE",
  "enrollmentInfo": {
    "enrollmentCount": 15,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2022-08-22",
    "completionDate": "2024-01-30",
    "primaryCompletionDate": "2024-01-30",
    "firstSubmitDate": "2021-12-02",
    "firstPostDate": "2021-12-16"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Caregivers are fluent/literate in English\n* Caregivers currently reside in the United States with spouse/family member who has received a medical diagnosis of Alzheimer's disease, other dementia, or mild cognitive impairment\n* Caregivers live in rural areas (using Rural-Urban Commuting Area Codes data)\n* Caregivers primarily use a smartphone (e.g., iPhone, Android)\n\nExclusion Criteria:\n\n* Caregivers providing care for individuals with known non-neurodegenerative conditions affecting behavior and cognition\n* Caregivers providing care for individuals with longstanding Axis I psychiatric disorder\n* Caregivers providing care for individuals with metabolic disorder or major organ dysfunction\n* Caregivers providing care for individuals with alcohol abuse or dependence (within 5 years of dementia onset)\n* Caregivers providing care for individuals with head trauma with loss of consciousness greater than 30 minutes\n* Caregivers providing care for individuals with contraindications to MRI imaging\n* Caregivers providing care for individuals with large confluent white matter lesions\n* Caregivers providing care for individuals with significant systemic medical illness\n* Caregivers providing care for individuals who use a medication likely to affect central nervous system functions adversely",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)",
        "description": "Questionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.",
        "timeFrame": "3 months after baseline"
      },
      {
        "measure": "6 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)",
        "description": "Questionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.",
        "timeFrame": "6 months after baseline"
      },
      {
        "measure": "3 Months Assessment for Zarit Burden Interview-Short Form",
        "description": "Questionnaire to measure caregiver burden (Zarit, Reever, \\& Bach-Peterson, 1980). 12 items are rated on 0-4 scale. Range: 0-48. No subscales. Higher scores represent worse outcomes.",
        "timeFrame": "3 months after baseline"
      },
      {
        "measure": "6 Months Assessment for Zarit Burden Interview-Short Form",
        "description": "Questionnaire to measure caregiver burden (Zarit, Reever, \\& Bach-Peterson, 1980). 12 items are rated on 0-4 scale. Range: 0-48. No subscales. Higher scores represent worse outcomes.",
        "timeFrame": "6 months after baseline"
      },
      {
        "measure": "3 Months Assessment for Beck Anxiety Inventory (BAI)",
        "description": "Questionnaire to measure anxiety (Beck, Epstein, Brown, \\& Steer, 1988). 20 items are rated on a 0-3 scale and summed (range= 0-60). Higher scores indicate worse outcomes. There are no subscales. A score greater than 36 is considered to be clinically significant.",
        "timeFrame": "3 months after baseline"
      },
      {
        "measure": "6 Months Assessment for Beck Anxiety Inventory (BAI)",
        "description": "Questionnaire to measure anxiety (Beck, Epstein, Brown, \\& Steer, 1988). 20 items are rated on a 0-3 scale and summed (range= 0-60). Higher scores indicate worse outcomes. There are no subscales. A score greater than 36 is considered to be clinically significant.",
        "timeFrame": "6 months after baseline"
      },
      {
        "measure": "3 Months Assessment for Satisfaction With Life Scale",
        "description": "Questionnaire measuring overall life satisfaction and well-being (Diener, Emmons, Larsen, \\& Griffin, 1985). 5 items scored on a 1-7 scale and summed (Range = 5-35). Lower scores indicate worse outcomes. A score of 20 is considered neutral with higher scores considered increasingly more satisfied and lower scores considered increasingly more dissatisfied.",
        "timeFrame": "3 months after baseline"
      },
      {
        "measure": "6 Months Assessment for Satisfaction With Life Scale",
        "description": "Questionnaire measuring overall life satisfaction and well-being (Diener, Emmons, Larsen, \\& Griffin, 1985). 5 items scored on a 1-7 scale and summed (Range = 5-35). Lower scores indicate worse outcomes. A score of 20 is considered neutral with higher scores considered increasingly more satisfied and lower scores considered increasingly more dissatisfied.",
        "timeFrame": "6 months after baseline"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 8,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 8
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:41.173Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}